BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 38139220)

  • 1. Germline Variants in Cancer Predisposition Genes in Pediatric Patients with Central Nervous System Tumors.
    Jovanović A; Tošić N; Marjanović I; Komazec J; Zukić B; Nikitović M; Ilić R; Grujičić D; Janić D; Pavlović S
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline genetic landscape of pediatric central nervous system tumors.
    Muskens IS; Zhang C; de Smith AJ; Biegel JA; Walsh KM; Wiemels JL
    Neuro Oncol; 2019 Nov; 21(11):1376-1388. PubMed ID: 31247102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic predisposition to central nervous system tumors in children - what the neurosurgeon should know.
    Foss-Skiftesvik J; Stoltze UK
    Acta Neurochir (Wien); 2022 Nov; 164(11):3025-3034. PubMed ID: 35660974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of Genomic Sequencing in Pediatric CNS Tumors.
    Bavle AA; Lin FY; Parsons DW
    Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition and evolutionary traces of pediatric cancer risk: a prospective 5-year population-based genome sequencing study of children with CNS tumors.
    Stoltze UK; Foss-Skiftesvik J; van Overeem Hansen T; Byrjalsen A; Sehested A; Scheie D; Stamm Mikkelsen T; Rasmussen S; Bak M; Okkels H; Thude Callesen M; Skjøth-Rasmussen J; Gerdes AM; Schmiegelow K; Mathiasen R; Wadt K
    Neuro Oncol; 2023 Apr; 25(4):761-773. PubMed ID: 35902210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients.
    Wagener R; Walter C; Auer F; Alzoubi D; Hauer J; Fischer U; Varghese J; Dugas M; Borkhardt A; Brozou T
    Int J Cancer; 2023 Apr; 152(7):1388-1398. PubMed ID: 36468172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine.
    You YN; Borras E; Chang K; Price BA; Mork M; Chang GJ; Rodriguez-Bigas MA; Bednarski BK; Meric-Bernstam F; Vilar E
    Dis Colon Rectum; 2019 Apr; 62(4):429-437. PubMed ID: 30730459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer.
    Sylvester DE; Chen Y; Grima N; Saletta F; Padhye B; Bennetts B; Wright D; Krivanek M; Graf N; Zhou L; Catchpoole D; Kirk J; Latchoumanin O; Qiao L; Ballinger M; Thomas D; Jamieson R; Dalla-Pozza L; Byrne JA
    Genes Chromosomes Cancer; 2022 Feb; 61(2):81-93. PubMed ID: 34687117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary predisposition to tumors of the central and peripheral nervous systems].
    Sourty B; Rousseau A
    Ann Pathol; 2020 Apr; 40(2):168-179. PubMed ID: 32192808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary central nervous system sarcoma with DICER1 mutation-treatment results of a novel molecular entity in pediatric Peruvian patients.
    Diaz Coronado RY; Mynarek M; Koelsche C; Mora Alferez P; Casavilca Zambrano S; Wachtel Aptowitzer A; Sahm F; von Deimling A; Schüller U; Spohn M; Sturm D; Pfister SM; Morales La Madrid A; Sernaque Quintana R; Sarria Bardales G; Negreiros Chinchihuara T; Ojeda Medina L; Garcia-Corrochano Medina P; Campos Sanchez DA; Ponce Farfan J; Rutkowski S; Garcia Leon JL
    Cancer; 2022 Feb; 128(4):697-707. PubMed ID: 34674226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline cancer predisposition variants and pediatric glioma: a population-based study in California.
    Muskens IS; de Smith AJ; Zhang C; Hansen HM; Morimoto L; Metayer C; Ma X; Walsh KM; Wiemels JL
    Neuro Oncol; 2020 Jun; 22(6):864-874. PubMed ID: 31970404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations.
    Kim J; Jeong K; Jun H; Kim K; Bae JM; Song MG; Yi H; Park S; Woo GU; Lee DW; Kim TY; Lee KH; Im SA
    Hum Genomics; 2023 Jan; 17(1):2. PubMed ID: 36604691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Looking beyond year 1 in the molecular era of pediatric brain tumor diagnosis: confirmatory testing of germline variants found on tumor sequencing.
    Greene BL; Stasi SM; Ting MA; Waligorski N; Cole BL; Lockwood CM; Paulson VA; Buchan JG; Lee A; Ojemann JG; Ellenbogen RG; Stevens J; Leary SES
    Front Oncol; 2024; 14():1338022. PubMed ID: 38511139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults.
    Ji J; Kaneva K; Hiemenz MC; Dhall G; Davidson TB; Erdreich-Epstein A; Hawes D; Hurth K; Margol AS; Mathew AJ; Robison NJ; Schmidt RJ; Tran HN; Judkins AR; Cotter JA; Biegel JA
    Neurooncol Adv; 2021; 3(1):vdab037. PubMed ID: 33948563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
    Sylvester DE; Chen Y; Jamieson RV; Dalla-Pozza L; Byrne JA
    J Med Genet; 2018 Dec; 55(12):785-793. PubMed ID: 30287599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohort.
    Foss-Skiftesvik J; Stoltze UK; van Overeem Hansen T; Ahlborn LB; Sørensen E; Ostrowski SR; Kullegaard SMA; Laspiur AO; Melchior LC; Scheie D; Kristensen BW; Skjøth-Rasmussen J; Schmiegelow K; Wadt K; Mathiasen R
    Acta Neuropathol Commun; 2022 Aug; 10(1):123. PubMed ID: 36008825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Sequencing of Malignant Supratentorial Pediatric Brain Tumors Demonstrates a High Frequency of Clinically Relevant Mutations.
    Cole BL; Pritchard CC; Anderson M; Leary SE
    Pediatr Dev Pathol; 2018; 21(4):380-388. PubMed ID: 29173061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study across pediatric central nervous system tumors implicates shared predisposition and points to 1q25.2 (PAPPA2) and 11p12 (LRRC4C) as novel candidate susceptibility loci.
    Foss-Skiftesvik J; Hagen CM; Mathiasen R; Adamsen D; Bækvad-Hansen M; Børglum AD; Nordentoft M; Werge T; Christiansen M; Schmiegelow K; Juhler M; Mortensen PB; Hougaard DM; Bybjerg-Grauholm J
    Childs Nerv Syst; 2021 Mar; 37(3):819-830. PubMed ID: 33226468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline Genetic Features of Young Individuals With Colorectal Cancer.
    Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
    Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.